BioAge Labs
"BioAge is a privately-held biotechnology company developing proprietary drugs to treat aging and aging- related diseases."
"Since its founding in 2015, the Company has raised $127 million in venture capital funding to back its AI-driven approach to map the molecular pathways that impact human longevity."
"BioAge’s mission is to develop a pipeline of therapeutic assets that increase healthspan and lifespan. For additional information about BioAge, visit the company’s website at www.bioagelabs.com."
Latest BioAge Labs News & Features
26 January 2021
4 December 2020
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze